Oryzon Genomics S.A. (FRA:ORN)
3.130
+0.050 (1.62%)
At close: Nov 27, 2025
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €257.06 million as of December 1, 2025. Its market cap has increased by 160.14% in one year.
Market Cap
257.06M
Enterprise Value
244.07M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.13
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 257.06M, an increase of 110.71%. That is a compound annual growth rate of 7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 257.06M | 183.75% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | 210.12M | 66.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |